Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Vi-DT
BIOLOGICAL
2 trials
Sponsors
International Vaccine Institute
Conditions
Typhoid
Phase 1
Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
Completed
NCT02645032
International Vaccine Institute
Typhoid
Start: 2016-05-19
End: 2017-02-09
Updated: 2020-04-28
Phase 2
Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine
Completed
NCT03527355
International Vaccine Institute
Typhoid
Start: 2018-04-18
End: 2021-01-19
Updated: 2021-08-27
Related Papers
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose.
2022-01-27
6 citations
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study.
2020-09-09
15 citations
Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report
Vaccine
2019-10-01
21 citations
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
2018-06-01
36 citations